-
Morand, E, Golder, V, Kandane-Rathnayake, R, Huq, M, Nim, H, Louthrenoo, W, Luo, SF, Lateef, A, Sockalingam, S, Navarra, S, et al.
26 Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study.
a19.1 -a1a19
2019
view publication
-
Morand, E, Golder, V, Kandane-Rathnayake, R, Huq, M, Nim, H, Louthrenoo, W, Luo, SF, Lateef, A, Sockalingam, S, Navarra, S, et al.
25 Prospective multicenter validation of the lupus low disease activity state (LLDAS) treatment target.
a18.2 -a1a18
2019
view publication
-
Ong, J, Nim, H, Hoi, AY.
223 Feasibility of a novel disease progress reporting system to facilitate shared decision making between physicians and patients in SLE.
a168.1 -a1a168
2019
view publication
-
McMaster, C, Nim, H, Koelmeyer, R, Frauman, A, Morand, E, Hoi, AY.
218 Therapeutic trajectories following high disease activity state in SLE.
a162.2 -a1a163
2019
view publication
-
Nim, HT, Connelly, K, Vincent, FB, Petitjean, F, Hoi, A, Koelmeyer, R, Boyd, SE, Morand, EF.
Novel Methods of Incorporating Time in Longitudinal Multivariate Analysis Reveals Hidden Associations With Disease Activity in Systemic Lupus Erythematosus..
Front Immunol
10:
1649
2019
view publication